Immunosuppressant Therapeutic Drug Monitoring Tests - Medical Devices Pipeline Assessment, 2020

Summary

The publisher's Medical Devices sector report, “Immunosuppressant Therapeutic Drug Monitoring Tests - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Immunosuppressant Therapeutic Drug Monitoring Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Immunosuppressant Therapeutic Drug Monitoring are the reagents used for the detection of immunosuppressant concentration in human body are covered under immunosuppressant TDM surgical devices that are used to make a tiny incision in the areas to be operated.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

Extensive coverage of the Immunosuppressant Therapeutic Drug Monitoring Tests under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Immunosuppressant Therapeutic Drug Monitoring Tests and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment/industry

Reasons to Buy

The report enables you to -

Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Identify and understand important and diverse types of Immunosuppressant Therapeutic Drug Monitoring Tests under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product’s current stage of development, territory and estimated launch date

1 Table of Contents

1.1 List of Tables
1.2 List of Figures

2 Introduction

2.1 Immunosuppressant Therapeutic Drug Monitoring Tests Overview

3 Products under Development

3.1 Immunosuppressant Therapeutic Drug Monitoring Tests - Pipeline Products by Stage of Development
3.2 Immunosuppressant Therapeutic Drug Monitoring Tests - Pipeline Products by Segment
3.3 Immunosuppressant Therapeutic Drug Monitoring Tests - Pipeline Products by Territory
3.4 Immunosuppressant Therapeutic Drug Monitoring Tests - Pipeline Products by Regulatory Path
3.5 Immunosuppressant Therapeutic Drug Monitoring Tests - Pipeline Products by Estimated Approval Date

4 Immunosuppressant Therapeutic Drug Monitoring Tests - Pipeline Products under Development by Companies

4.1 Immunosuppressant Therapeutic Drug Monitoring Tests Companies - Pipeline Products by Stage of Development
4.2 Immunosuppressant Therapeutic Drug Monitoring Tests - Pipeline Products by Stage of Development

5 Immunosuppressant Therapeutic Drug Monitoring Tests Companies and Product Overview6 Immunosuppressant Therapeutic Drug Monitoring Tests - Recent Developments

7 Appendix

7.1 Methodology
7.2 About the Publisher
7.3 Contact
7.4 Disclaimer

List of Tables

Table 1: Immunosuppressant Therapeutic Drug Monitoring - Pipeline Products by Stage of Development
Table 2: Immunosuppressant Therapeutic Drug Monitoring - Pipeline Products by Territory
Table 3: Immunosuppressant Therapeutic Drug Monitoring - Pipeline Products by Regulatory Path
Table 4: Immunosuppressant Therapeutic Drug Monitoring - Pipeline Products by Estimated Approval Date
Table 5: Immunosuppressant Therapeutic Drug Monitoring Companies - Pipeline Products by Stage of Development
Table 6: Immunosuppressant Therapeutic Drug Monitoring - Pipeline Products by Stage of Development
Table 7: BIOHOPE Scientific SL Pipeline Products & Ongoing Clinical Trials Overview
Table 8: Immunobiogram - Renal Transplantation - Product Status
Table 9: Immunobiogram - Renal Transplantation - Product Description
Table 10: Laboratory Corp of America Holdings Pipeline Products & Ongoing Clinical Trials Overview
Table 11: DoseASSURE RTX Assay - Product Status
Table 12: DoseASSURE RTX Assay - Product Description
Table 13: Ortho-Clinical Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 14: VITROS XT 7600 Integrated System - Cedia Cyclosporine Assay - Product Status
Table 15: VITROS XT 7600 Integrated System - Cedia Cyclosporine Assay - Product Description
Table 16: VITROS XT 7600 Integrated System - Cedia Mycophenolic Acid Assay - Product Status
Table 17: VITROS XT 7600 Integrated System - Cedia Mycophenolic Acid Assay - Product Description
Table 18: VITROS XT 7600 Integrated System - Methotrexate Assay - Product Status
Table 19: VITROS XT 7600 Integrated System - Methotrexate Assay - Product Description
Table 20: VITROS XT 7600 Integrated System - QMS Everolimus Assay - Product Status
Table 21: VITROS XT 7600 Integrated System - QMS Everolimus Assay - Product Description
Table 22: VITROS XT 7600 Integrated System - QMS Tacrolimus Assay - Product Status
Table 23: VITROS XT 7600 Integrated System - QMS Tacrolimus Assay - Product Description
Table 24: Progenika Biopharma SA Pipeline Products & Ongoing Clinical Trials Overview
Table 25: Promonitor - Autoimmune And Inflammation - Product Status
Table 26: Promonitor - Autoimmune And Inflammation - Product Description
Table 27: Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 28: Cobas - Cyclosporin A Assay - Product Status
Table 29: Cobas - Cyclosporin A Assay - Product Description
Table 30: Cobas 4000 Analyzer Series With e 411 Module - Cyclosporine Assay - Product Status
Table 31: Cobas 4000 Analyzer Series With e 411 Module - Cyclosporine Assay - Product Description
Table 32: Cobas 4000 Analyzer Series With e 411 Module - Tacrolimus Assay - Product Status
Table 33: Cobas 4000 Analyzer Series With e 411 Module - Tacrolimus Assay - Product Description
Table 34: Cobas 6000 Analyzer Series With c 501 Module - Cyclosporine Assay - Product Status
Table 35: Cobas 6000 Analyzer Series With c 501 Module - Cyclosporine Assay - Product Description
Table 36: Cobas 6000 Analyzer Series With c 501 Module - Everolimus Assay - Product Status
Table 37: Cobas 6000 Analyzer Series With c 501 Module - Everolimus Assay - Product Description
Table 38: Cobas 6000 Analyzer Series With c 501 Module - Sirolimus Assay - Product Status
Table 39: Cobas 6000 Analyzer Series With c 501 Module - Sirolimus Assay - Product Description
Table 40: Cobas 6000 Analyzer Series With c 501 Module - Tacrolimus Assay - Product Status
Table 41: Cobas 6000 Analyzer Series With c 501 Module - Tacrolimus Assay - Product Description
Table 42: Cobas 6000 Analyzer Series With e 601 Module - Cyclosporine Assay - Product Status
Table 43: Cobas 6000 Analyzer Series With e 601 Module - Cyclosporine Assay - Product Description
Table 44: Cobas 6000 Analyzer Series With e 601 Module - Everolimus Assay - Product Status
Table 45: Cobas 6000 Analyzer Series With e 601 Module - Everolimus Assay - Product Description
Table 46: Cobas 6000 Analyzer Series With e 601 Module - Sirolimus Assay - Product Status
Table 47: Cobas 6000 Analyzer Series With e 601 Module - Sirolimus Assay - Product Description
Table 48: Cobas 8000 Analyzer Series With c 502 Module - Everolimus Assay - Product Status

List of Figures

Figure 1: Immunosuppressant Therapeutic Drug Monitoring - Pipeline Products by Stage of Development
Figure 2: Immunosuppressant Therapeutic Drug Monitoring - Pipeline Products by Territory
Figure 3: Immunosuppressant Therapeutic Drug Monitoring - Pipeline Products by Regulatory Path
Figure 4: Immunosuppressant Therapeutic Drug Monitoring - Pipeline Products by Estimated Approval Date